Page last updated: 2024-12-10

3-nitrobenzhydrazide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3291498
CHEMBL ID124596
SCHEMBL ID432613
MeSH IDM0052634

Synonyms (52)

Synonym
BB 0240536
STL301567
[3-(hydrazinylcarbonyl)phenyl](hydroxy)oxoammonium
nsc123864
nsc-123864
3-nitrobenzoylhydrazine
m-nitrobenzoylhydrazine
m-nitrobenzoylhydrazide
3-nitrobenzhydrazide
nsc-3558
m-nitrobenzoic acid hydrazide
m-nitrobenzhydrazide
m-nitrobenzoic hydrazide
nsc3558
618-94-0
3-nitrobenzoic acid hydrazide
3-nitrobenzohydrazide
STK035803
AKOS000200509
3-nitro-benzoic acid hydrazide
CHEMBL124596
N0147
A833472
nsc 178021
benzoic acid, m-nitro-, hydrazide
meta-nitrobenzhydrazide
ai3-08824
nsc 3558
einecs 210-572-5
nsc 123864
benzoic acid, 3-nitro-, hydrazide
AKOS016034598
3-nitrobenzenecarbohydrazide
FT-0616238
AKOS022133504
SCHEMBL432613
AB01319733-02
3-nitro-benzenecarbohyrazide
3-nitrobenzoic acid, hydrazide
DTXSID0060690
m-nitrobenzhydrazid
3-nitrobenzohydrazide #
AS-8439
F0191-0160
mfcd00017059
EN300-17362
F52345
NCGC00324989-01
3-nitrobenzoic hydrazide
CS-0149879
SY076512
Z56922145
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1059231Antitubercular activity against Mycobacterium tuberculosis2013European journal of medicinal chemistry, , Volume: 70Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
AID1059234Lipophilicity, log P of the compound2013European journal of medicinal chemistry, , Volume: 70Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
AID143262Minimum inhibitory concentration against Mycobacterium tuberculosis var. bovis strain at 310K, with value expressed as pMIC i.e. -log of MIC (ug/mL).2004Journal of medicinal chemistry, Jul-15, Volume: 47, Issue:15
Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]